Arne Bleijenberg1, Dagmar Klotz2,3, Magnus Løberg2,3, Evelien Dekker1, Hans Olov Adami2,4, Ernst J Kuipers5, Øyvind Holme6, Mette Kalager7, Louise Emilsson7,8, Britta Kleist9, Leif Løvdal9, Jaroslaw Regula10,11, Else M Løberg12, Joep IJspeert1, Michael Bretthauer2,3. 1. Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Cancer Center Amsterdam, Amsterdam, The Netherlands. 2. Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway. 3. Departments of Pathology and Transplantation Medicine, Oslo University Hospital, Oslo, Norway. 4. Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. 5. Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. 6. University of Oslo and Cancer Registry of Norway, Oslo, and Sorlandet Hospital Trust, Kristiansand, Norway. 7. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 8. Department of Health Management and Health Economy, Institute of Health and Society, University of Oslo, Norway. 9. Department of Pathology, Soerlandet Sykehus HF, Kristiansand, Norway. 10. Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, and Department of Cancer Prevention, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. 11. Department of Oncological Gastroenterology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. 12. Department of Pathology, Oslo University Hospital, Ullevål, Oslo, Norway.